Background: Research evidence has highlighted the relevance of endocrine/metabolic abnormalities in psychiatry and of psychosocial implications in endocrinology. However, the value of interdisciplinary expertise has not been implemented in clinical practice. We have therefore designed a new outpatient clinic, called the Psychoneuroendocrinology Service, to apply the principles of current psychosomatic medicine and report here on the first 100 referrals. Methods and Results: Of the first 100 patients (74 females/26 males; mean age 44 ± 13.8 years), the sources of referral were the Mental Health Center (n = 41), specialists (n = 37) and primary care physicians (n = 22). The main reasons for referral were endocrine assessment (n = 40), unexplained medical symptoms (n = 18) and poor response to treatment (n = 17). The most frequent medical diagnoses were obesity/overweight (n = 22), hypertension (n = 20) and hypothyroidism (n = 11). The most frequent psychiatric diagnoses were major depression (n = 15), schizophrenia/schizoaffective disorder (n = 13) and bipolar disorder (n = 12). Subclinical symptoms (Diagnostic Criteria for Psychosomatic Research) found were persistent somatization (n = 18), demoralization (n = 14) and irritable mood (n = 7). Therapeutic strategies included lifestyle modifications (n = 45), explanatory therapy (n = 30), low-dose clonazepam (n = 23) and modifications of existing treatment with psychotropic drugs (n = 16). Conclusions: In this highly selected population, several difficult patients could be appropriately managed by virtue of a holistic view. Such an approach must involve experienced clinicians with a broad-spectrum training in psychoneuroendocrinology and psychosomatic medicine. If confirmed in its efficacy and cost-effectiveness, this model might be further expanded.

1.
Newcomer JW: Second-generation (atypical) antipsychotics and metabolic effects. A comprehensive literature review. CNS Drugs 2005;19(suppl 1):1–93.
2.
Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K: First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2008;192:406–411.
3.
Szalat A, Mazeh H, Freund HR: Lithium- associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol 2009;160:317–323.
4.
Sonino N, Tomba E, Fava GA: Psychosocial approach to endocrine disease; in Porcelli P, Sonino N (eds): Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Adv Psychosom Med. Basel, Karger, 2007, vol 28, pp 21–33.
5.
Månsson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landén M: Women with polycystic ovary syndrome are often depressed or anxious – a case control study. Psychoneuroendocrinology 2008;33:1132–1138.
6.
Sievers C, Ising M, Pfister H, Dimopoulou C, Schneider HJ, Roemmler J, Schopohl J, Stalla GK: Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur J Endocrinol 2009;160:367–373.
7.
Fava GA, Sonino N: The clinical domains of psychosomatic medicine. J Clin Psychiatry 2005;66:849–855.
8.
Porcelli P, Sonino N (eds): Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Adv Psychosom Med. Basel, Karger, 2007, vol 28.
9.
Ferrari S, Galeazzi GM, Mackinnon A, Rigatelli M: Frequent attenders in primary care: impact of medical, psychiatric and psychosomatic diagnoses. Psychother Psychosom 2008;77:306–314.
10.
Figueira ML, Ouakinin S: From psychosomatic to psychological medicine: what’s the future? Curr Opinion Psychiatry 2008;21:412–416.
11.
Goldthorpe JH, Hope K: The Social Grading of Occupations. Oxford, Oxford University Press, 1974.
12.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, American Psychiatric Association, 1994.
13.
Sonino N, Fava GA: A simple instrument for assessing stress in clinical practice. Postgrad Med J 1998;74:408–410.
14.
Sonino N, Ruini C, Navarrini C, Ottolini F, Sirri L, Paoletta A, Fallo F, Boscaro M, Fava GA: Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) 2007;67:719–726.
15.
Feinstein AR: Clinimetrics. New Haven, Yale University Press, 1987.
16.
Sirri L, Grandi S, Fava GA: The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom 2008;77:337–350.
17.
Fava GA, Grandi S, Rafanelli C, Fabbri S, Cazzaro M: Explanatory therapy in hypochondriasis. J Clin Psychiatry 2000;61:317–322.
18.
Kellner R: Psychotherapeutic strategies in the treatment of psychophysiologic disorders. Psychother Psychosom 1979;32:91–100.
19.
Chouinard G: Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004;65(suppl 5):7–12.
20.
Nardi AE, Perna G: Clonazepam in the treatment of psychiatric disorders: an update. Int Clin Psychopharmacol 2006;21:131–142.
21.
Fava GA, Sonino N: The biopsychosocial model thirty years later. Psychother Psychosom 2008;77:1–2.
22.
Fava GA, Sonino N: Psychosomatic assessment. Psychother Psychosom 2009;78:333–341.
23.
Sobrinho LG: Psychopathology in endocrine disorders: why so persistent after the cure? Psychother Psychosom 2004;73:65–67.
24.
Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA: Personality characteristics and quality of life in patients treated for Cushing’s syndrome. Clin Endocrinol 2006;64:314–318.
25.
Sonino N, Fava GA: Rehabilitation in endocrine patients: a novel psychosomatic approach. Psychother Psychosom 2007;76:319–324.
26.
Sonino N: The need for rehabilitation teams in endocrinology. Expert Rev Endocrinol Metab 2008;3:291–293.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.